{"id":"https://openalex.org/W2011155558","doi":"https://doi.org/10.1016/s1470-2045(09)70201-3","title":"Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomised controlled trials","display_name":"Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomised controlled trials","publication_year":2009,"publication_date":"2009-08-11","ids":{"openalex":"https://openalex.org/W2011155558","doi":"https://doi.org/10.1016/s1470-2045(09)70201-3","mag":"2011155558","pmid":"https://pubmed.ncbi.nlm.nih.gov/19674936","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2748902"},"language":"en","primary_location":{"id":"doi:10.1016/s1470-2045(09)70201-3","doi":"https://doi.org/10.1016/s1470-2045(09)70201-3","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s1470-2045(09)70201-3","pdf_url":"http://www.thelancet.com/article/S1470204509702013/pdf","source":{"id":"https://openalex.org/S116900674","display_name":"The Lancet Oncology","issn_l":"1470-2045","issn":["1470-2045","1474-5488"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.thelancet.com/article/S1470204509702013/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025921361","display_name":"David Paul Dearnaley","orcid":"https://orcid.org/0000-0002-3954-2806","observed_orcids":["https://orcid.org/0000-0002-3954-2806"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David P Dearnaley","raw_affiliation_strings":["Royal Marsden Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032518609","display_name":"Malcolm David Mason","orcid":"https://orcid.org/0000-0003-1505-2869","observed_orcids":["https://orcid.org/0000-0003-1505-2869"]},"institutions":[{"id":"https://openalex.org/I4210091428","display_name":"MRC Clinical Trials Unit at UCL","ror":"https://ror.org/001mm6w73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I4210087105","https://openalex.org/I4210091428","https://openalex.org/I45129253","https://openalex.org/I90344618"]},{"id":"https://openalex.org/I4210150388","display_name":"Velindre Cancer Centre","ror":"https://ror.org/049sr1d03","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799279586","https://openalex.org/I4210150388"]},{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Malcolm D Mason","raw_affiliation_strings":["MRC Clinical Trials Unit , London , UK","School of Medicine, Cardiff University, Velindre Hospital, Cardiff, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Clinical Trials Unit , London , UK","institution_ids":["https://openalex.org/I4210091428"]},{"raw_affiliation_string":"School of Medicine, Cardiff University, Velindre Hospital, Cardiff, UK","institution_ids":["https://openalex.org/I4210150388","https://openalex.org/I79510175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014097745","display_name":"Mahesh Parmar","orcid":"https://orcid.org/0000-0003-0166-1700","observed_orcids":["https://orcid.org/0000-0003-0166-1700","https://orcid.org/0000-0002-8883-424X"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210091428","display_name":"MRC Clinical Trials Unit at UCL","ror":"https://ror.org/001mm6w73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I4210087105","https://openalex.org/I4210091428","https://openalex.org/I45129253","https://openalex.org/I90344618"]},{"id":"https://openalex.org/I90344618","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517","country_code":"GB","type":"government","lineage":["https://openalex.org/I4210087105","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mahesh KB Parmar","raw_affiliation_strings":["Royal Marsden Foundation Trust and Institute of Cancer Research , Sutton , Surrey , UK","MRC Clinical Trials Unit, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden Foundation Trust and Institute of Cancer Research , Sutton , Surrey , UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]},{"raw_affiliation_string":"MRC Clinical Trials Unit, London, UK","institution_ids":["https://openalex.org/I4210091428","https://openalex.org/I90344618"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109931784","display_name":"Karen Sanders","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091428","display_name":"MRC Clinical Trials Unit at UCL","ror":"https://ror.org/001mm6w73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I4210087105","https://openalex.org/I4210091428","https://openalex.org/I45129253","https://openalex.org/I90344618"]},{"id":"https://openalex.org/I90344618","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517","country_code":"GB","type":"government","lineage":["https://openalex.org/I4210087105","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Karen Sanders","raw_affiliation_strings":["MRC Clinical Trials Unit, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Clinical Trials Unit, London, UK","institution_ids":["https://openalex.org/I4210091428","https://openalex.org/I90344618"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059261043","display_name":"Matthew Robert Sydes","orcid":"https://orcid.org/0000-0002-9323-1371","observed_orcids":["https://orcid.org/0000-0002-9323-1371"]},"institutions":[{"id":"https://openalex.org/I4210091428","display_name":"MRC Clinical Trials Unit at UCL","ror":"https://ror.org/001mm6w73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I4210087105","https://openalex.org/I4210091428","https://openalex.org/I45129253","https://openalex.org/I90344618"]},{"id":"https://openalex.org/I90344618","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517","country_code":"GB","type":"government","lineage":["https://openalex.org/I4210087105","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Matthew R Sydes","raw_affiliation_strings":["MRC Clinical Trials Unit, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Clinical Trials Unit, London, UK","institution_ids":["https://openalex.org/I4210091428","https://openalex.org/I90344618"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5059261043"],"corresponding_institution_ids":["https://openalex.org/I4210091428","https://openalex.org/I90344618"],"apc_list":{"value":7280,"currency":"USD","value_usd":7280},"apc_paid":{"value":7280,"currency":"USD","value_usd":7280},"fwci":11.8154,"has_fulltext":true,"cited_by_count":203,"citation_normalized_percentile":{"value":0.99099154,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"10","issue":"9","first_page":"872","last_page":"876"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.0066999997943639755,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bisphosphonates","display_name":"bisphosphonates","score":0.9800000190734863},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.9789999723434448},{"id":"https://openalex.org/keywords/metastatic-prostate-cancer","display_name":"metastatic prostate cancer","score":0.8880000114440918},{"id":"https://openalex.org/keywords/locally-advanced-prostate-cancer","display_name":"locally advanced prostate cancer","score":0.9679999947547913},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.9210000038146973},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9369999766349792},{"id":"https://openalex.org/keywords/bone-metastases","display_name":"bone metastasis","score":0.7870000004768372},{"id":"https://openalex.org/keywords/hormone-therapy","display_name":"hormone therapy","score":0.7260000109672546},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.6840000152587891},{"id":"https://openalex.org/keywords/mortality-risk-reduction","display_name":"mortality risk reduction","score":0.3610000014305115},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.32899999618530273},{"id":"https://openalex.org/keywords/osteonecrosis-of-the-jaw","display_name":"osteonecrosis of the jaw","score":0.6150000095367432}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9029943346977234},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6001837849617004},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5988144874572754},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.5826737880706787},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5755926966667175},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4783187210559845},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4681466221809387},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.4341820180416107},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4331216812133789},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4293438494205475},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.40359580516815186},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.08957463502883911},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.07750123739242554},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0611606240272522}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001859","descriptor_name":"Bone Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001859","descriptor_name":"Bone Neoplasms","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D001859","descriptor_name":"Bone Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D004002","descriptor_name":"Clodronic Acid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017024","descriptor_name":"Chemotherapy, Adjuvant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018931","descriptor_name":"Antineoplastic Agents, Hormonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D050071","descriptor_name":"Bone Density Conservation Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1016/s1470-2045(09)70201-3","doi":"https://doi.org/10.1016/s1470-2045(09)70201-3","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s1470-2045(09)70201-3","pdf_url":"http://www.thelancet.com/article/S1470204509702013/pdf","source":{"id":"https://openalex.org/S116900674","display_name":"The Lancet Oncology","issn_l":"1470-2045","issn":["1470-2045","1474-5488"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2748902","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2748902","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lancet Oncol","raw_type":"Text"},{"id":"pmid:19674936","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19674936","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet. Oncology","raw_type":"Journal Article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:1304932","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/1304932/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"LANCET ONCOL , 10 (9) 872 - 876. (2009)","raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1016/s1470-2045(09)70201-3","doi":"https://doi.org/10.1016/s1470-2045(09)70201-3","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s1470-2045(09)70201-3","pdf_url":"http://www.thelancet.com/article/S1470204509702013/pdf","source":{"id":"https://openalex.org/S116900674","display_name":"The Lancet Oncology","issn_l":"1470-2045","issn":["1470-2045","1474-5488"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7528670117","display_name":null,"funder_award_id":"10588","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"}],"funders":[{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2011155558.pdf","grobid_xml":"https://content.openalex.org/works/W2011155558.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W1975441355","https://openalex.org/W1986114421","https://openalex.org/W2045995359","https://openalex.org/W2073380111","https://openalex.org/W2086008590","https://openalex.org/W2088392474","https://openalex.org/W2117328200","https://openalex.org/W2117511763","https://openalex.org/W2118610033","https://openalex.org/W2132441555","https://openalex.org/W2136112016","https://openalex.org/W2144498681","https://openalex.org/W2148096512","https://openalex.org/W2151840803","https://openalex.org/W2158878352","https://openalex.org/W2900642847"],"related_works":["https://openalex.org/W2151840803","https://openalex.org/W2136112016","https://openalex.org/W7098663865","https://openalex.org/W2273419105","https://openalex.org/W2330174066","https://openalex.org/W2058094811","https://openalex.org/W2058227557","https://openalex.org/W1978445096","https://openalex.org/W4249903801","https://openalex.org/W2045321361"],"abstract_inverted_index":{"BACKGROUND:":[0],"Bisphosphonates":[1],"might":[2],"modulate":[3],"the":[4,27,38,85,91,167,182,191,211,255],"development":[5],"of":[6,29,41,127,178,187,225,235,271,317],"symptomatic":[7],"bone":[8],"metastases":[9],"in":[10,48,155,160,181,190,243,273,301,320],"men":[11,53,67,80,97,110,157,180,189,213,257,302,321],"with":[12,45,54,68,214,230,239,258,268,276,279,303,322],"prostate":[13,305,324],"cancer.":[14,325],"The":[15],"Medical":[16],"Research":[17],"Council":[18],"(MRC)":[19],"PR05":[20,60,183],"and":[21,63,65,162,185,206,329,333],"PR04":[22,74,192],"randomised":[23],"controlled":[24],"trials":[25,290],"assessed":[26,150],"use":[28,234],"sodium":[30,128,236,296],"clodronate,":[31,297],"an":[32,152,318,330],"oral,":[33],"first-generation":[34,294],"bisphosphonate.":[35],"We":[36],"report":[37],"final":[39],"analyses":[40],"long-term":[42,103],"survival":[43,148,245,275,300],"data":[44,165,175,287],"additional":[46],"follow-up":[47],"both":[49],"trials.":[50],"METHODS:":[51],"311":[52,179],"metastatic":[55,94,215,231,304],"disease":[56,70,232],"were":[57,71,81,98,118,219,263],"recruited":[58,72],"to":[59,73,77,84,102,121,137,221,265],"between":[61],"1994":[62,76],"1998,":[64],"508":[66,188],"non-metastatic":[69,107,259,323],"from":[75,166,233,288,336],"1997.":[78],"All":[79],"treated":[82],"according":[83],"recruiting":[86],"site's":[87],"standard":[88],"practice":[89],"at":[90,158],"time:":[92],"for":[93,106,135,176,228],"disease,":[95,108,216,260],"all":[96,156],"starting":[99,309],"or":[100,115,132,142],"responding":[101],"hormone":[104,113,310],"therapy;":[105],"most":[109],"had":[111],"radiotherapy,":[112],"therapy,":[114,311],"both.":[116],"Men":[117],"randomly":[119],"assigned":[120],"take":[122],"four":[123],"tablets":[124],"per":[125],"day":[126],"clodronate":[129,237,277],"(2080":[130],"mg)":[131],"matching":[133],"placebo":[134,240,280],"up":[136],"3":[138],"years":[139,144],"(metastatic":[140],"disease)":[141],"5":[143],"(non-metastatic).":[145],"Long-term":[146,286],"overall":[147,244,274,299],"was":[149,241],"on":[151],"intention-to-treat":[153],"basis":[154],"sites":[159],"England":[161],"Wales":[163],"using":[164],"National":[168],"Health":[169],"Service":[170],"Information":[171],"Centre,":[172],"which":[173],"held":[174],"278":[177,212],"trial":[184],"471":[186,256],"trial.":[193],"These":[194],"studies":[195],"are":[196,308],"registered":[197],"International":[198],"Standardised":[199],"Randomised":[200],"Controlled":[201],"Trials,":[202],"numbers":[203],"ISRCTN38477744":[204],"(PR05)":[205],"ISRCTN61384873":[207],"(PR04).":[208],"FINDINGS:":[209],"Of":[210,254],"258":[217],"(93%)":[218],"reported":[220,264],"have":[222,266],"died.":[223],"Evidence":[224],"a":[226,293],"benefit":[227],"those":[229],"compared":[238,278],"seen":[242],"(hazard":[246],"ratio":[247],"[HR]":[248],"0.77,":[249],"95%":[250],"CI":[251],"0.60-0.98;":[252],"p=0.032).":[253],"281":[261],"(60%)":[262],"died,":[267],"no":[269,315],"evidence":[270,316],"improvement":[272],"(HR":[281],"1.12,":[282],"0.89-1.42;":[283],"p=0.94).":[284],"INTERPRETATION:":[285],"these":[289],"show":[291],"that":[292],"bisphosphonate,":[295],"improves":[298],"cancer":[306],"who":[307],"but":[312],"there":[313],"is":[314],"effect":[319],"FUNDING:":[326],"UK":[327],"MRC;":[328],"education":[331],"grant":[332],"free":[334],"drug":[335],"Roche":[337],"Products":[338],"Ltd.":[339]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":13},{"year":2017,"cited_by_count":15},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":12},{"year":2014,"cited_by_count":26},{"year":2013,"cited_by_count":17},{"year":2012,"cited_by_count":24}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}